US Drug Recall Register

FDA Drug Recalls

1,709 recalls · Class III, newest first

Class III · Low risk Terminated

Tivicay

Reason Cross Contamination with Other Products: Product contains Promacta (eltrombopag).

Viiv Healthcare Company NDC 49702-228-13 D-1185-2014
Class III · Low risk Terminated

Photofrin

Reason Stability Data Does Not Support Expiry: Printed expiration date should be Nov 2013 rather than Nov 2014.

Pinnacle Biologics Inc D-1157-2014
Class III · Low risk Terminated

Gelnique

Reason Subpotent Drug: Drug potency was compromised during shipment.

Actavis D-1088-2014
Class III · Low risk Terminated

Tussin CF Adult Maximum Strength Multi-Symptom Cold liquid

Reason Presence of Precipitate: Recall is due to complaints of a white substance, confirmed as Guaifenesin, an active ingredient in the product which is precipitating out.

Aaron Industries Inc NDC 49035-229-08 D-1097-2014
Class III · Low risk Terminated

Derma-Smoothe/FS fluocinolone acetonide 0.01% Topical Oil

Reason Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.

Hill Dermaceuticals, Inc. NDC 28105-150-04 D-1175-2014
Class III · Low risk Terminated

Derma-Smoothe/FS fluocinolone acetonide 0.01% Topical Oil

Reason Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.

Hill Dermaceuticals, Inc. NDC 28105-149-04 D-1174-2014
Class III · Low risk Terminated

DermOtic Oil

Reason Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.

Hill Dermaceuticals, Inc. NDC 28105-160-20 D-1173-2014
Class III · Low risk Terminated

Triamcinolone Acetonide Cream USP

Reason Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.

Fougera Pharmaceuticals Inc. NDC 0168-0004-80 D-1152-2014
Class III · Low risk Terminated

Carisoprodol Tablets

Reason Failed Impurity/degradation Specification

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-819-20 D-1155-2014
Class III · Low risk Terminated

Suprax

Reason Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.

Lupin Pharmaceuticals Inc. NDC 27437-207-03 D-1187-2014
Class III · Low risk Terminated

Suprax

Reason Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.

Lupin Pharmaceuticals Inc. NDC 27437-207-02 D-1186-2014
Class III · Low risk Terminated

Liptruzet

Reason Defective Container; some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.

Merck & Co Inc NDC 66582-323-30 D-1312-2014
Class III · Low risk Terminated

Liptruzet

Reason This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.

Merck & Co Inc NDC 66582-322-30 D-1311-2014
Class III · Low risk Terminated

Liptruzet

Reason This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.

Merck & Co Inc NDC 66582-321-30 D-1310-2014
Class III · Low risk Terminated

Liptruzet

Reason This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.

Merck & Co Inc NDC 66582-320-30 D-1309-2014
Class III · Low risk Terminated

Zithromax

Reason Failed Impurities/Degradation Specifications: Pfizer is recalling certain lots due to out of specification results for azithromycin N-oxide degradant.

Pfizer Inc. NDC 0069-3150-84 D-745-2014
Class III · Low risk Terminated

Cetirizine Hydrochloride Syrup

Reason Failed impurities/degradation specifications; out of specification for the known impurity 4-chlorobenzophenone.

Qualitest Pharmaceuticals NDC 0603-9063-54 D-394-2014
Class III · Low risk Terminated

VoLumen Barium Sulfate Suspension

Reason Failed Stability Testing: This product is below specification for preservative content.

Bracco Diagnostics Inc NDC 32909-945-03 D-1083-2014
Class III · Low risk Terminated

Folic Acid Injection

Reason Failed Impurities/Degradation specifications: out-of-specification results 14 & 15 month time point

Fresenius Kabi USA, LLC NDC 63323-184-11 D-379-2014